I am/have/had
I am looking for
Advanced Filters
Found 233 clinical trials
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients
The primary objective is to determine whether SAR408701 improves the overall survival (OS) when compared with docetaxel in participants with metastatic non-squamous NSCLC expressing CEACAM5 2+ in intensity in at least 50% of the tumor cell population and previously treated with standard-of-care platinum-based chemotherapy and an immune checkpoint inhibitor.
measurable disease
squamous nsclc (non-small cell lung cancer)
docetaxel
pulmonary metastasis
platinum-based chemotherapy
- 0 views
- 19 Feb, 2024
- 52 locations
